Printer Friendly

Browse Teriparatide topic

Articles

1-11 out of 11 article(s)
Title Author Type Date Words
Conclusion Of A Non-exclusive Discount Agreement Pursuant To 130a (8) Sgb V On The Active Substance Teriparatide (atc H05aa02), For The Period 1.8.2018 - 31.7.2020. Jun 12, 2018 515
Conclusion Of A Non-exclusive Discount Agreement Pursuant To 130a (8) Sgb V On The Active Substance Teriparatide (atc H05aa02), For The Period 1.6.2018 - 31.5.2020. Apr 20, 2018 512
Conclusion Of A Non-exclusive Discount Agreement Pursuant To 130a Para. 8 Sgb V Concerning Drugs With The Active Substance Teriparatide (atc Code: H05aa02) Within The Period From 1 December 2017 To 30.11.2019. Oct 21, 2017 504
Choose teriparatide, then denosumab in osteoporosis. Kling, Jim Oct 15, 2017 617
Teriparatide tops risedronate in vertebral fracture risk. Kling, Jim Oct 15, 2017 467
Bilateral Incomplete Atypical Femoral Fracture due to Long-Term Bisphosphonate Use: A Case Report/Uzun Sureli Bifosfonat Kullanimina Bagli Olarak Gelisen Bilateral Inkomplet Atipik Femur Frakturu: Bir Olgu Sunumu. Basaran, Sibel; Benlidayi, Ilke Coskun; Akin, Burcak; Guzel, Rengin Case study Aug 1, 2017 2999
Pilot study: teriparatide was effective in 81% of premenopausal women with idiopathic osteoporosis. Goldstein, Steven R. Dec 1, 2013 514
Anabolic agent may augment Osteoporosis Tx. (Teriparatide still needs FDA Aapproval). Bates, Betsy May 1, 2002 511
Teriparatide sparks talk of combined therapy. (Osteoporosis Treatments). Bates, Betsy Brief Article Apr 15, 2002 495
Teriparatide shown to strengthen bone: awaiting FDA approval for osteoporosis. (Clinical Rounds). Bates, Betsy Apr 15, 2002 527
FDA Panel Backs Injectable Osteoporosis Drug. DEMOTT, KATHRYN Brief Article Sep 1, 2001 785

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters